Protecting product pipeline and rising above competition through optimisation of operationally efficient, specifically targeted oncology clinical trials
We are thrilled to announce the great success of our 2nd Annual Clinical Operations in Oncology Europe. All those in attendance left with key takeaways to ensure their oncology trials are run efficiently.
Topics covered included designing robust clinical studies, protocols, and conduct, tackling challenges in global clinical trials, pinpointing patient centric approaches, as well as exploring the financials involved and implementing risk-based monitoring.
We look forward to seeing you in 2016!
The key challenge facing clinical trials for cancer patients is patient participation. More so in the field of cancer than in others due to a number of different reasons, from high competition for patients to the struggles to find enough patients with the specific cancer you are fighting. So how can you increase patient participation for your trial?
Who will be there and what you will achieve?